Skip to search form
Skip to main content
>
Semantic Scholar
Semantic Scholar's Logo
Search
Sign In
Create Free Account
You are currently offline. Some features of the site may not work correctly.
Lemtrada
National Institutes of Health
Create Alert
Related topics
Related topics
3 relations
1.2 ML alemtuzumab 10 MG/ML Injection [Lemtrada]
alemtuzumab Injection [Lemtrada]
Broader (1)
alemtuzumab
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
[Updated recommendations of the Council of Experts on the use and safety of alemtuzumab (Lemtrada)].
N. Khachanova
,
K. Bakhtiyarova
,
+9 authors
F. Khabirov
Zhurnal nevrologii i psikhiatrii imeni S.S…
2020
Corpus ID: 216084777
Alemtuzumab (Lemtrada) is a recombinant humanized IgG1 kappa monoclonal antibody to the surface cell glycoprotein, a CD52…
Expand
2019
2019
195 MS disease modifying therapy (DMT) sequencing – tysabri to mavenclad de-escalation in JC-virus positive MS patients
T. Mihalova
,
K. Vernon
,
Nazar Sharaf
,
P. Talbot
,
D. Rog
Journal of Neurology, Neurosurgery, and…
2019
Corpus ID: 214445270
Background There is a significant UK variation in the DMT sequencing strategies for high PML risk patients on Tysabri. In Greater…
Expand
2017
2017
[Clinical recommendations on the use of alemtuzumab (lemtrada)].
V. Alifirova
,
G. Bisaga
,
+11 authors
T. E. Schmidt
Zhurnal nevrologii i psikhiatrii imeni S.S…
2017
Corpus ID: 34321771
2017
2017
Klinicheskie rekomendatsii po primeneniiu preparata alemtuzumab (lemtrada).
V. Alifirova
,
G. Bisaga
,
+11 authors
T. E. Schmidt
2017
Corpus ID: 105132246
2016
2016
Leki immunomodulacyjne a ciąża w stwardnieniu rozsianym
Iwona Rościszewska-Żukowska
,
M. Dziki
,
H. Bartosik-Psujek
2016
Corpus ID: 171930484
Stwardnienie rozsiane cześciej wystepuje u kobiet, a szczyt zachorowan przypada na wiek rozrodczy. Dlatego zagadnienie ciązy w…
Expand
2015
2015
Clinical edge: Treatment of multiple sclerosis with lemtrada
J. King
2015
Corpus ID: 80356968
From 1 April 2015, Lemtrada (alemtuzumab) became available in Australia on the PBS for the treatment of relapsing forms of…
Expand
Review
2015
Review
2015
NEW DRUG APPROVALS Blincyto for Rare Form of ALL
2015
Corpus ID: 35935741
NEW DRUG APPROVALS Blincyto for Rare Form of ALL The FDA has approved blinatumomab (Blincyto, Amgen) to treat patients with…
Expand
2013
2013
Removal of access to alemtuzumab for patients with aggressive multiple sclerosis
A. Thompson
,
G. Giovannoni
BMJ
2013
Corpus ID: 206897779
Those who have already received a course of the drug need access until its re-release
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE